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Abstract
Background:  Cholestatic jaundice as a presenting symptom of Precursor T-lymphoblastic
leukemia (T-ALL)/lymphoma (T-LBL) has never been reported in literature. Similarly, precursor T-
ALL/T-LBL is characteristically negative for synaptophysin. We report the first case of a patient
with precursor T-ALL/T-LBL who presented with cholestatic jaundice and aberrant tumor
expression of synaptophysin.
Case report: 42 year old male presented with anorexia, nausea, jaundice, pale stools, dark urine
and about 35 pound weight loss over the previous 3 weeks. The initial laboratory work was
suggestive of cholestatic jaundice. Markedly elevated LDH (2025 U/L) and CA 19-9 (1778 u/ML)
were also noticed. The CT scan of abdomen showed massive hepatomegaly with coarse
echotexture with contracted gall bladder and normal sized common bile duct. Chest x-ray revealed
a mediastinal mass with mediastinal widening. CT scan of the chest showed anterior mediastinal
mass (16 cm × 10 cm). CT guided biopsy of the mass showed malignant lymphoma with diffuse
proliferation of medium sized lymphoid cells. The neoplastic cells were positive for CD1a, CD3,
CD4, CD5, CD8 and CD43 with aberrant expression of synaptophysin. PET CT scan again showed
a large anterior mediastinal mass with diffuse liver involvement and abnormal activity in axial bones.
CT guided liver biopsy and bone marrow biopsy revealed the same morphology and
immunohistochemistry. Bone marrow aspirate showed 85% lymphoblasts. Thus, the diagnosis of
precursor T-ALL/T-LBL was made and jaundice with elevated CA 19-9 were attributed to
intrahepatic cholestasis.
Conclusion:  Our case illustrates an unusual presentation of hematological malignancies as
cholestatic jaundice. It also indicates the non-specific nature of CA 19-9 for pancreaticobiliary
malignancies. It is the first case report of neoplastic precursor T cell lymphoblasts with unusual
expression of synaptophysin. Tissue biopsy with thorough immunohistochemistry is required to
differentiate precursor T-ALL/T-LBL from thymoma and small cell carcinoma.
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Background
Precursor T-lymphoblastic leukemia (T-ALL)/lymphoma
(T-LBL) is a neoplasm of lymphoblasts committed to the
T-cell lineage. Clinically, if there are >25 percent bone
marrow blasts with or without a mass lesion, the term pre-
cursor T-ALL is used. The term precursor T-LBL is used, if
there is a mass lesion with less than 25 percent bone mar-
row involvement [1]. However, due to their biologic unity
and significant clinical overlap, T-ALL and T-LBL are con-
sidered the same disease with different clinical presenta-
tions [2]. Our case highlights two unusual manifestations
of precursor T-ALL/T-LBL, namely, the rare initial presen-
tation of cholestatic jaundice and the aberrant expression
of synaptophysin by the tumor cells both of which, to the
best of our knowledge, have not been reported before.
Case report
42 year old obese (BMI-38) caucasian male presented to
his primary care provider with complaints of insidious
onset of anorexia, nausea, jaundice, pale stools, dark urine
and about 35 pound weight loss over the previous 3
weeks. Outpatient laboratory work up revealed normal
complete blood counts and basic panel but deranged liver
function tests suggestive of cholestatic jaundice. Patient
was then referred to a regional medical center for imaging
studies. Ultrasound of abdomen showed multiple hyper-
echoic and hypoechoic liver lesions all less than 1 cm in
size. The CT scan of abdomen showed massive hepatome-
galy with coarse echotexture with contracted gall bladder
and normal sized common bile duct. A chest x-ray (Figure
1A) obtained at the same time revealed a huge mediasti-
nal mass with evidence of mediastinal widening. CT scan
of the chest (Figure 1B) showed 3 anterior mediastinal
masses with the largest one being 16 cm × 10 cm. In view
of these imaging studies, the patient was referred to a ter-
tiary care center for further work up. Upon arrival, we
found the patient to be significantly icteric with some
abdominal distension. There was smooth, non-tender
liver edge palpable 10 cm below the right costal margin.
No peripheral lymphadenopathy was noticed. The labora-
tory work on admission showed normal CBC and basic
panel but persistently deranged liver function tests (Table
1).
Additional work up was ordered which showed cerulo-
plasmin 5 mg/dl, AFP <1.3 ng/dl and serum ferritin 4686
ng/ml. ANA, anti-smooth muscle antibodies, HIV, along
with EBV and CMV antibodies were all negative. CT
guided biopsy of the mediastinal mass (Figure 2A)
showed features of malignant lymphoma characterized by
a diffuse proliferation of medium sized lymphoid cells,
which exhibited fine nuclear chromatin, inconspicuous
nucleoli and scanty cytoplasm. Occasional mitosis with
few scattered tangible body macrophages was noted. The
neoplastic cells were positive for CD1a (Figure 2B), CD3
(Figure 2D), CD4, CD5, CD8 and CD43. The neoplastic T
cells also expressed synaptophysin (Figure 2C). However,
the tumor was negative for CD20, kappa and lambda light
chain immunoglobulins, CD34, TDT, cytokeratin AE1/
AE3, cytokeratin 5.2 and CD56. The proliferation fraction
(Ki-67) was 100%. Next, a PET CT scan (Figure 1C, D) was
ordered which again showed a very large anterior medias-
tinal mass extending across the mediastinum from left to
right and superiorly into the supraclavicular area. Diffuse
liver involvement and abnormal activity in axial bones
were also noticed. CT guided liver biopsy (Figure 2E) and
bone marrow biopsy (Figure 2F) revealed the same tumor
cell morphology with identical immunohistochemistry. A
200-cell count with differential performed on bone mar-
row aspirate showed 85% lymphoblasts, 2% small mature
lymphocytes, 6% segmented neutrophils, 2% intermedi-
ate granulocytic precursors and 5% erythroid precursors.
Ultrasound of bilateral testes was negative. MRI brain
showed no masses or infarcts. Lumbar puncture was nor-
mal with no lymphoblasts. Thus, the diagnosis of precur-
sor T-ALL/T-LBL was made. Since this patient had more
than 25 percent T lymphoblasts in his bone marrow aspi-
rate, his disorder could be best described as precursor T-
ALL. After having considered the highly deranged liver
function tests, per the recommendations of the treating
oncologist, the treatment was initiated with cisplatin and
dexamethasone (CD) for a total of 3 cycles to be followed
by 4 cycles of Hyper CVAD. Follow up on day 100 after the
completion of 3 cycles of Hyper CVAD revealed a normal
hepatic panel and normal LDH (Table 1) with the patient
scheduled for a fourth round of Hyper CVAD and a subse-
quent referral to a bone marrow transplant center.
Discussion
Cholestatic jaundice as an initial presentation of acute
lymphoblastic leukemia (ALL) is exceedingly rare [3,4]. A
histopathological study of liver from autopsies of
untreated patients diagnosed with leukemia or lym-
phoma did not reveal any evidence of cholestasis [5].
Majority of the cases reported describe cholestatic jaun-
dice due to extrahepatic bile duct obstruction as a present-
ing feature of acute leukemia [6,7] Whereas Kelleher et al
have reported intrahepatic cholestasis as initial presenta-
tion of precursor B-ALL in two children [8]; our literature
search did not reveal any case of intrahepatic cholestasis
in association with precursor T-ALL/T-LBL. We report the
first case of a patient with precursor T-ALL/T-LBL who pre-
sented with intrahepatic cholestasis.
This patient had presented with painless jaundice, pale
stools, direct hyperbilirubinemia, non-dilated common
bile duct and multiple liver lesions suggestive of intrahe-
patic cholestasis. The significantly elevated serum CA 19-
9 level was later attributed to the cholestatic jaundice
rather than primary hepatobiliary and pancreatic malig-
nancies [3]. This represents the nonspecific nature of this
tumor marker [9].Journal of Hematology & Oncology 2009, 2:12 http://www.jhoonline.org/content/2/1/12
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This patient had a bulky anterior mediastinal mass.
Masses in the anterior compartment are more likely to be
malignant than those found in the other mediastinal
compartments [10]. Thymomas are the most common
anterior mediastinal primary neoplasms in adults [11].
Symptoms due to myasthenia gravis or other tumor-
related syndromes are present in 35 percent of patients
with thymoma at diagnosis [5]. Small cell lung cancer
presents most commonly as a large hilar mass with bulky
mediastinal adenopathy. Therefore, tissue biopsy with
thorough immunohistochemical analysis is important to
differentiate between thymomas, small cell lung cancers
Chest X-ray, CT chest and PET/CT images. Figure 1
Chest X-ray, CT chest and PET/CT images. A. A chest x-ray (Frontal view) showing a huge mediastinal mass with evi-
dence of mediastinal widening. B. CT scan of the chest showing 3 anterior mediastinal masses with the largest one being 16 cm 
× 10 cm. C. PET image revealing a very large anterior mediastinal mass and a diffuse liver involvement along with abnormal 
activity in both humeri, femura, and pelvic bones. D. Fusion PET/CT image showing a very large anterior mediastinal mass 
extending across the mediastinum from left to right and superiorly into the supraclavicular area. A diffuse involvement of the 
liver along with abnormal activity in both humeri, femura, and pelvic bones were also noticed.Journal of Hematology & Oncology 2009, 2:12 http://www.jhoonline.org/content/2/1/12
Page 4 of 6
(page number not for citation purposes)
and lymphomas. Thymomas are composed of a mixture
of neoplastic epithelial cells and non-neoplastic T lym-
phocytes, small cell carcinomas are characterized by small
"blue" malignant cells about twice the size of lym-
phocytes, whereas T cell Lymphomas are composed of
neoplastic T lymphocytes. The tumor cells in this patient
were cytokeratin negative indicating their non-epithelial
origin and thus, making the diagnosis of thymoma
unlikely. These cells were also negative for most of the
neural and neuroendocrine markers except for synapto-
physin. This helped rule out small cell carcinoma. Further,
these cells were positive for CD1a, sCD3, CD4/CD8 dou-
ble positive indicating that neoplastic cells were in fact T
cell lymphoblasts [2] more specifically, the common thy-
omocytes which represent an intermediate intrathymic
maturation stage for T lymphoblasts. The lack of tumor
cell expression of CD34 and TdT markers, as seen in this
patient, is more common in precursor T-ALL than in pre-
cursor B-ALL [12]. Thus, tissue biopsy with thorough
immunohistochemistry is required to differentiate T-ALL
from thymoma and small cell carcinoma.
It was, however, unusual that these T cell lymphoblasts
had aberrant expression of synaptophysin, an immunocy-
tochemical marker for neuroendocrine differentiation
(Figure 2C). Our literature search did not reveal synapto-
physin positivity in any case of lymphoma or leukemia.
Whether this aberrant expression of synaptophysin in pre-
cursor T-ALL/T-LBL carries any prognostic significance
remains to be evaluated.
Conclusion
To our knowledge, this is the first case report of precursor
T-ALL/T-LBL presenting as cholestatic jaundice in an adult
and also of neoplastic precursor T cell lymphoblasts
expressing synaptophysin. It also indicates the non-spe-
cific nature of CA 19-9 for pancreaticobiliary malignan-
cies. Tissue biopsy with thorough immunohistochemistry
is required to differentiate precursor T-ALL/T-LBL from
thymoma and small cell carcinoma.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
Table 1: showing results of laboratory workup on admission at the tertiary care center (Day 0), during hospitalization (Day 7) and on 
outpatient follow up (day 100).
Laboratory 
Tests
Normal 
Range
On admission
(Day 0)
On Day 7  
(1 day before
chemotherapy)
On Day  
(after 3 cy of CD
100  and 3 cy of
Hyper CVAD 
chemotherapy)
ALT 2–45 U/L 130 270 33
AST 10–40 U/L 107 253 22
Alk. Phos. 0–120 U/L 894 1371 94
Total Protein 6.0–8.0 g/dL 6.7 5.9 6.2
Albumin 3.6–5.0 g/dL 3.3 3.0 3.3
Total Bili. 0.2–1.2 mg/dL 7.9 14.8 0.6
Direct Bili. 0.0–0.3 mg/dL 6.1 - -
Indirect Bili. 0.0–0.9 mg/dL 1.8 - -
PT 9–11.5 sec 12.5 - 10.6
LDH 100–225 U/L 2026 1838 220
Ammonia 13–37 μmol/L 72 - -
CA 19-9 0–35 U/mL 1778.6 - -
AST (Aspartate Transaminase), ALT (Alanine Transaminase), Alk. Phos. (Alkaline Phosphatase), Bili. (Bilirubin), PT (Prothrombin Time), LDH 
(Lactate Dehydrogenase) cy (cycles) and CD (cisplatin - dexamethasone).Journal of Hematology & Oncology 2009, 2:12 http://www.jhoonline.org/content/2/1/12
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H&E staining and immunohistochemical characteristics of tumor cells Figure 2
H&E staining and immunohistochemical characteristics of tumor cells. A. CT guided biopsy of the mediastinal mass 
(H&E staining) showing diffuse proliferation of medium sized lymphoid cells, exhibiting fine nuclear chromatin, inconspicuous 
nucleoli and scanty cytoplasm. Occasional mitosis with few scattered tangible body macrophages was noted. An area of necro-
sis was also noticed within the tumor. B. CD1a positive neoplastic cells from mediastinal biopsy aspirate. C. Synaptophysin pos-
itive neoplastic cells from mediastinal biopsy aspirate. D. CD3 positive neoplastic cells from mediastinal biopsy aspirate. E. H&E 
staining of the CT guided liver biopsy revealing the same tumor cell morphology as that of CT guided mediastinal mass biopsy. 
It also revealed intrahepatic cholestasis in the form of intracanalicular bile plugs. F. H&E staining of the bone marrow biopsy 
showing the same tumor cell morphology as that of CT guided mediastinal mass biopsy.Publish with BioMed Central    and   every 
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images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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